U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086079) titled 'A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)' on July 18.
Brief Summary: The goal of this study is to learn what happens to doravirine (DOR) and islatravir (ISL) in a healthy lactating female's body over time. Researchers want to learn if DOR and ISL are in breast milk.
Study Start Date: Aug. 25
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: DOR/ISL
Oral tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Merck Sharp & Dohme LLC
Published by HT Digital Content Services with permission from Health Daily Digest....